Status:

UNKNOWN

Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI

Lead Sponsor:

Tongji Hospital

Conditions:

Remimazolam

Awake Endotracheal Intubation

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

1. To study the pharmacokinetics between remimazolam besylate and alfentanil; 2. To determine the optimal dosage of the two drugs in awake endotracheal intubation; 3. To provide clinical guidance for ...

Detailed Description

Tracheal intubation is the most effective and reliable method to establish artificial airway, which provides the best conditions for relieving airway obstruction, ensuring airway patency, removing res...

Eligibility Criteria

Inclusion

  • no predictable difficult airway, Mallampati grade Ⅰ-II;
  • deviation from ideal body weight ≤25%;
  • \[Ideal weight (kg) = height (cm) -100 (male) or 105 (female)\]
  • American Society of Anesthesiologists grade Ⅰ-II;
  • Informed consent: voluntarily participate in the trial and sign the informed consent.

Exclusion

  • patients with head and neck lesions (including malignant tumors, previous surgery or radiotherapy), limited mouth opening, limited neck extension, obstructive sleep apnea, morbid obesity, and progressive airway injury;
  • Relative contraindications: patients with respiratory diseases, allergy to local anesthetics, airway bleeding, and non-cooperation;
  • patients known to be allergic to remimazolam besylate or benzodiazepines;
  • patients with known allergy to alfentanil or opioids;
  • body weight exceeding ±25% of ideal body weight;
  • patients with coagulation dysfunction, endocrine diseases or other hemodynamic conditions;
  • patients with a history of drug or alcohol dependence;
  • Subjects who were deemed unsuitable for the study by the investigators.

Key Trial Info

Start Date :

April 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT06026566

Start Date

April 1 2023

End Date

December 31 2025

Last Update

September 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University

Wuhan, Hubei, China, 430030